Literature DB >> 21437559

Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.

G Watfa1, C Dragonas, T Brosche, R Dittrich, C C Sieber, C Alecu, A Benetos, R Nzietchueng.   

Abstract

BACKGROUND: Many studies have shown that short telomere length (TL) is associated with high oxidative stress and various age-related diseases. Parkinson's disease (PD) is an age-related disease, and although its pathogenic mechanism is uncertain, oxidative stress is believed to be implicated in this pathology. The aim of this case-control study was to assess both TL and the different markers of oxidative stress in elderly patients with PD compared to age control subjects.
METHODS: 20 PD patients and 15 age-matched controls, >65 years were studied. TL was measured by Southern blotting from DNA samples extracted from white blood cells. Superoxide dismutase (SOD) activity and plasma levels of total glutathione and protein carbonyls were determined.
RESULTS: There was a trend for lower TL in PD patients: 6.06 ± 0.81 kb in PD versus 6.45 ± 0.73 kb in controls (p = 0.08). No significant difference was found between the two groups in terms of oxidative stress markers. In controls, age was the main determinant of telomere shortening (r = -0.547; p = 0.03) whereas, in PD patients, telomere shortening was mainly dependent on plasmatic concentrations of carbonyl proteins (r= -0.544; p=0.044). In PD patients, a negative association was observed between plasma carbonyl protein levels and SOD activity (r= -0.622, p=0.004).
CONCLUSIONS: In PD, TL is shorter in presence of high oxidative stress as measured by carbonyl protein levels. The absence of telomere attrition with age among patients with PD could reflect a telomere regulation by mechanisms other than age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21437559     DOI: 10.1007/s12603-010-0275-7

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  36 in total

1.  Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease.

Authors: 
Journal:  Pathophysiology       Date:  2000-04

2.  Telomere length inversely correlates with pulse pressure and is highly familial.

Authors:  E Jeanclos; N J Schork; K O Kyvik; M Kimura; J H Skurnick; A Aviv
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

3.  Oxidative stress shortens telomeres.

Authors:  Thomas von Zglinicki
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

4.  Telomere shortening in T cells correlates with Alzheimer's disease status.

Authors:  L A Panossian; V R Porter; H F Valenzuela; X Zhu; Erin Reback; D Masterman; J L Cummings; R B Effros
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

5.  Telomere length and possible link to X chromosome.

Authors:  Tim S Nawrot; Jan A Staessen; Jeffrey P Gardner; Abraham Aviv
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

Review 6.  Telomeres and human aging: facts and fibs.

Authors:  Abraham Aviv
Journal:  Sci Aging Knowledge Environ       Date:  2004-12-22

7.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

8.  Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects.

Authors:  Athanase Benetos; Jeffrey P Gardner; Mahmoud Zureik; Carlos Labat; Lu Xiaobin; Chris Adamopoulos; Mohamed Temmar; Kathryn E Bean; Frédérique Thomas; Abraham Aviv
Journal:  Hypertension       Date:  2004-01-19       Impact factor: 10.190

9.  Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.

Authors:  D T Dexter; A E Holley; W D Flitter; T F Slater; F R Wells; S E Daniel; A J Lees; P Jenner; C D Marsden
Journal:  Mov Disord       Date:  1994-01       Impact factor: 10.338

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  25 in total

1.  Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice.

Authors:  Girish Chandran
Journal:  Cell Mol Neurobiol       Date:  2013-07-19       Impact factor: 5.046

Review 2.  Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators.

Authors:  Volkan Ergin; Reza Ebrahimi Hariry; Cimen Karasu
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

3.  Telomere length and Parkinson's disease in men: a nested case-control study.

Authors:  M Schürks; J Buring; R Dushkes; J M Gaziano; R Y L Zee; T Kurth
Journal:  Eur J Neurol       Date:  2013-09-07       Impact factor: 6.089

Review 4.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

Review 5.  Does oxidative stress shorten telomeres in vivo? A review.

Authors:  Sophie Reichert; Antoine Stier
Journal:  Biol Lett       Date:  2017-12       Impact factor: 3.703

6.  Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation.

Authors:  Elsa Vera; Nazario Bosco; Lorenz Studer
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

Review 7.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

8.  Telomere length in Parkinson's disease: A meta-analysis.

Authors:  Diego A Forero; Yeimy González-Giraldo; Catalina López-Quintero; Luis J Castro-Vega; George E Barreto; George Perry
Journal:  Exp Gerontol       Date:  2016-01-07       Impact factor: 4.032

Review 9.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

Review 10.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.